心力衰竭合并瓣膜性心脏病介入治疗研究现状  

Current study of interventional therapy for heart failure complicated with valvular heart disease

作　　者：丁建东[1] 马根山[1] DING Jian-dong;MA Gen-shan(Department of Cardiology,Zhongda Hospital,Southeast University,Nanjing 210009,China)

机构地区：[1]东南大学附属中大医院心内科,江苏南京210009

出　　处：《中国实用内科杂志》2020年第12期990-995,共6页Chinese Journal of Practical Internal Medicine

基　　金：江苏省重点研发课题(7790000104)。

摘　　要：随着人口老龄化,瓣膜性心脏病的发生率逐渐增加,常导致心力衰竭。心力衰竭也可引起心脏结构的改变,导致继发性瓣膜病变。最常见的瓣膜病变是二尖瓣反流和主动脉瓣狭窄。以心导管为基础的介入治疗的迅速发展为心力衰竭合并瓣膜性心脏病的治疗带来了重大突破。With the aging of the population,the incidence of valvular heart disease(VHD)is gradually increasing,often leading to heart failure(HF). HF can also cause changes in the structure of the heart and lead to secondary valvular disease.The most common valvular diseases are mitral valve regurgitation and aortic stenosis. The rapid development of interventional therapy based on cardiac catheters has brought a major breakthrough in the treatment of heart failure complicated with valvular heart disease.

关 键 词：心力衰竭 瓣膜性心脏病 主动脉瓣狭窄 二尖瓣反流 经导管主动脉瓣置换术 经皮缘对缘二尖瓣修复术 

分 类 号：R541.6[医药卫生—心血管疾病]